A ten-year study led by researchers at the University of Birmingham has found that helper T cells, a central part of the immune system, carry a lasting chemical imprint of obesity that can persist for five to ten years after a person has slimmed down.
The findings help explain why people who have lost significant weight still face raised risks of type 2 diabetes, cardiovascular disease and some cancers.
The work, published in the journal EMBO Reports in April 2026, focused on CD4+ helper T cells, immune cells that coordinate the body's response to infection and inflammation.
In these cells, obesity leaves behind changes to DNA methylation, chemical tags that switch genes on or off without altering the DNA sequence itself.
Also read: Study links neighborhood in youth to heart health later in life
According to the University of Birmingham press release, those tags are likely to remain on the cells for five to ten years after successful weight loss, keeping immune activity tilted toward inflammation long after the scale has moved.
What the researchers actually did
The team, working with collaborators at Queen Mary University of London and Maynooth University in Ireland, pulled together several human cohorts alongside animal work.
They analyzed immune cells from patients using weight-loss injections, from people with Alstrom Syndrome (a rare genetic condition that causes early-onset obesity), and from participants in a 10-week exercise program, as reported by Inside Precision Medicine.
Tissue and blood samples were also taken from patients having hip or knee replacements, allowing the team to compare immune cells across normal-weight and obese donors.
Also read: Your sleep quality could be raising your heart disease risk
Mice on high-fat diets rounded out the picture, letting the researchers track what happened when the animals switched back to a normal diet.
The pattern was consistent across the groups. Weight loss brought clear metabolic improvements, but the epigenetic changes on helper T cells did not disappear with the pounds.
Two systems that stay out of tune
The study, described in more detail by News-Medical, points to two cellular processes that stay disrupted.
One is autophagy, the routine by which cells clear out damaged parts and recycle them.
Also read: A new headset can treat your depression without medication
The other is immune senescence, the gradual aging of the immune system.
When those two systems drift, T cells become less flexible and more inflammatory.
That kind of low-grade, chronic inflammation is closely tied to the diseases that track with obesity, from insulin resistance, meaning the body's cells respond less effectively to insulin, to atherosclerosis and certain cancers.
The researchers also flagged specific genes with reduced methylation, including Bcl6 and CDKN1C, as candidates for driving that persistent inflammatory tone.
Also read: These vaccines and health checks are relevant after 50
What it means if you have lost weight
Professor Claudio Mauro of the University of Birmingham, who led the work, said the results should shift how quickly people expect their disease risk to fall.
"The findings suggest that short-term weight loss may not immediately reduce the risk of some disease conditions associated with obesity, including type 2 diabetes and some cancers," Mauro said in the university's statement.
He added that the effect is not permanent. "Instead, ongoing weight management following loss will see the 'obesity memory' slowly fade. This may take several years of sustained weight loss maintenance, likely 5-10 years, though this requires further study, to fully reverse the effects of obesity on T cells."
That framing matters as GLP-1 medications reshape how millions of people lose weight.
Also read: Drinking coffee every day may cut your liver disease risk by nearly half
Sustained maintenance, not a single successful cut, appears to be what allows the immune system to reset.
Recent research also suggests that pairing pharmacological weight loss with regular activity brings extra protection that the drugs alone do not provide, a pattern seen in earlier work showing that only exercise actually protected the heart after GLP-1 weight loss.
A possible shortcut
The team stresses that testing whether such drugs actually shorten the immune "memory" of obesity will require dedicated trials.
For anyone who has already lost weight, the practical takeaway is simpler.
Keeping the weight off, year after year, is what gives immune cells time to forget.
If you have a history of obesity and are managing your weight, standard checks for blood pressure, blood sugar and cholesterol remain the concrete way to catch inflammation-linked disease early.
Those screenings are available through primary care.
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.